Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Hypertension Control Program in Argentina (HCPIA) [NA]
The Hypertension Control Program in Argentina (HCPIA) trial sponsored by Tulane University has completed.
-
CLINICAL_TRIALS withdrawal · 2017-07-17Clinical Trial Update: The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients [Phase 4]
A Phase 4 trial evaluating clevidipine for effects on intracranial pressure and cerebral perfusion pressure in brain-injured patients has be…
-
CLINICAL_TRIALS research · 2017-07-17Clinical Trial Update: Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG
A clinical trial update indicates the fimasartan study for hypertensive cardiac disease with left ventricular hypertrophy (ECG-estimated) ha…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Community Study to Reduce High Blood Pressure Through Text Messaging (REACH OUT) [NA]
A completed community-based trial evaluating text messaging to reduce high blood pressure, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Full Length Versus Proximal Renal Arteries Ablation [NA]
Completed clinical trial comparing full-length versus proximal renal arteries ablation in patients with resistant hypertension.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-07-17Clinical Trial Update: Detecting and Treating High Blood Pressure in Aboriginal Population and Low and Middle Income Countries [NA]
This clinical trial update concerns detecting and treating hypertension in Aboriginal populations and in low- and middle-income countries. T…
-
FDA approval · 2017-07-14FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc. The notice confirms regulatory approval o…
-
CLINICAL_TRIALS research · 2017-07-14Clinical Trial Update: Study of the Variations of the Blood Pressure After Nephrectomy for Renal Cancer (VAPANCR) [NA]
A clinical trial evaluating how blood pressure varies after nephrectomy in renal cancer patients. The current status is UNKNOWN.
-
CLINICAL_TRIALS research · 2017-07-14Clinical Trial Update: E_Stethoscope: Portable Digital Auscultation Study on Hypertensive/Hypertensive Heart Disease Patients
Clinical trial update describing a study of a portable digital auscultation device (E_Stethoscope) in patients with hypertension and hyperte…
-
FDA approval · 2017-07-13FDA Approved: EPLERENONE — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's original (ANDA) application for the generic drug eplerenone (Eplerenone). The product is intended for indic…
-
CLINICAL_TRIALS withdrawal · 2017-07-12Clinical Trial Update: Evaluation of Lysine-Specific Demethylase 1 [NA]
A clinical trial evaluating Lysine-Specific Demethylase 1 for hypertension has been withdrawn.
-
CLINICAL_TRIALS research · 2017-07-11Clinical Trial Update: Trial to Enhance Adherence to Multiple Guidelines [NA]
A completed clinical trial aimed at enhancing adherence to multiple clinical guidelines across several conditions.
-
CLINICAL_TRIALS research · 2017-07-11Clinical Trial Update: WAVE Study- Walking and Aging in VErona Study [NA]
A clinical trial update for the WAVE Study (Walking and Aging in Verona) involving obesity-related conditions, with study status currently u…
-
FDA approval · 2017-07-10FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Avalide (irbesartan and hydrochlorothiazide) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2017-07-07FDA Approved: DOXAZOSIN — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for generic doxazosin from Zydus Lifesciences Limited. This product provides a generic option for the …
-
CLINICAL_TRIALS research · 2017-07-06Clinical Trial Update: Smartphone App Assisted Home Blood Pressure Monitoring Amongst Hypertensive Patients in Singapore [NA]
This document provides a trial update on a smartphone app-assisted home blood pressure monitoring study in hypertensive patients in Singapor…
-
FDA approval · 2017-07-05FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves the original application for a generic fixed-dose combination of amlodipine and olmesartan medoxomil from Glenmark for the trea…
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: ACE Inhibitors Combined With Exercise for Seniors - Pilot Study
A pilot trial at the University of Florida evaluated the combination of ACE inhibitors with exercise in older adults with hypertension.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Breathe: Slow Paced Breathing to Lower Blood Pressure [NA]
A completed clinical trial sponsored by the National Institute on Aging evaluated slow-paced breathing as a non-pharmacologic method to redu…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Genetic Analysis of African-Americans With High Blood Pressure
A completed genetic analysis study sponsored by NHLBI focusing on African-Americans with hypertension, examining genetic factors related to …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Effects of Dark Chocolate on Insulin Sensitivity in People With High Blood Pressure [Phase 1]
This clinical trial update notes the completion of a Phase 1 study examining whether dark chocolate improves insulin sensitivity in people w…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Renal Denervation by MDT-2211 System in Patients With Uncontrolled Hypertension [NA]
A completed clinical trial evaluated the MDT-2211 Renal Denervation System for treating patients with uncontrolled hypertension.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: The Roles of Trust and Respect in Patient Reactions to Race-based and Personalized Medicine Vignettes: An Experimental Study
This completed experimental study funded by NHGRI examined how trust and respect influence patients' reactions to race-based and personalize…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Methods for Measuring Insulin Sensitivity
The NCCIH reports on clinical trial methods for measuring insulin sensitivity in participants with obesity, hypertension, and non-insulin-de…
-
EMA withdrawal · 2017-06-29EMA Expired: Sabervel (irbesartan) — Pharmathen S.A.
The EMA page indicates Sabervel (irbesartan) produced by Pharmathen S.A. has expired status in the European market for hypertension.